010600 — WellBiotec Co Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro Cap

Annual cashflow statement for WellBiotec Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS/A	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-67,825	-33,298	-21,024	-66,372	-21,376
Depreciation
Amortisation
Non-Cash Items	63,806	13,286	24,143	58,564	17,229
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-4,563	-2,026	-2,500	2,167	-3,123
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-5,705	-19,753	1,980	-4,168	-6,077
Capital Expenditures	-1,276	-763	-509	-1,083	-90.1
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-25,683	8,882	17,040	-21,548	10,038
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-26,959	8,120	16,531	-22,630	9,948
Financing Cash Flow Items	86.2	-79.7	-30.1	-55.7	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	23,781	13,701	-11,788	26,480	-5,623
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-8,910	2,161	6,504	-329	-1,415